Rory Farnan, MD
Interventional Cardiology · Fargo, NDNPI 1912223603
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,238 of the $5,973 with a category attached, or 70.9%. Medtronic accounts for 81.1% of it on its own, with 8 other manufacturers making up the rest.
Across 86 payments — averaging $69.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$467
- Biotronik Inc.$310
- Abbott$207
- Penumbra, Inc.$67
- Bard Peripheral Vascular, Inc.$31
- plus $48 from 3 others
What the payments were for
- Travel & lodging$4,23871%
- Food & beverage$1,73629%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $4,843 |
| Boston Scientific | 33 | $467 |
| Biotronik Inc. | 8 | $310 |
| Abbott | 4 | $207 |
| Penumbra, Inc. | 1 | $67 |
| Bard Peripheral Vascular, Inc. | 2 | $31 |
| Siemens Medical Solutions USA, Inc. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Advisa$2,517
- TurboHawk$1,457
- Assurity Pacemaker$176
How this compares
Too few interventional cardiology providers in North Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 108 | $107,631 |
| XareltoRivaroxaban | 50 | $57,022 |
| Repatha SureclickEvolocumab | 63 | $49,099 |
| FarxigaDapagliflozin Propanediol | 16 | $10,797 |
| BrilintaTicagrelor | 14 | $10,097 |
| Atorvastatin Calcium | 259 | $4,043 |
| Metoprolol Succinate | 194 | $3,074 |
| Ezetimibe | 114 | $2,504 |
| Ranolazine ErRanolazine | 30 | $2,137 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 30 | $1,650 |
| ClopidogrelClopidogrel Bisulfate | 83 | $1,118 |
| Furosemide | 101 | $968 |
| Potassium Chloride | 21 | $962 |
| Amlodipine Besylate | 138 | $953 |
| Colchicine | 14 | $941 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Fargo
- Alok SauravFargo$10K
- Puneet SharmaFargo$7K
- Yassar AlmanaseerFargo$7K
- Ismail BekdashFargo$6K
- Nayan DesaiBismarck$413K
- Hai XuBismarck$25K
- Jared SteinbergerBismarck$9K
- Yara Letitia CameronGrand Forks$8K
- Camelia IlieBismarck$1K
- John HoytBismarck$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.